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abstract
Objective: as a rule of thumb 30-40% of patients with ocD do not experience clinically relevant change from exposure 
and response prevention (ERP), and 50% can expect to be classified as recovered post treatment. The evidence is unclear 
as to whether comorbid personality disorders (PD) might be a factor negatively influencing treatment outcome. The aims 
of the current study were to investigate if PDs and magnitude of Axis-I diagnoses are related to poorer treatment outcome. 
Method: 47 ocD patients (15 male) received concentrated exposure therapy (cet) which consists of individually 
tailored and therapist assisted exposure therapy during 4 consecutive days. The treatment was delivered in a group 
format with a patient-therapist ration of 1:1. OCD-symptoms were assessed with Yale-Brown Obsessive Compulsive 
Scale (Y-BOCS) before treatment, at 1-week post-treatment, and at 3- and 6-months follow-up. Post treatment interviews 
were conducted by an independent rater. Patients were screened for PDs with Standardized Assessment of Personality, 
Abbreviated Scale (SAPAS). 
Results: Pre-treatment the PD group did not have more severe OCD-symptoms as compared to the group without. Post 
treatment 79% of the patients were classified as recovered, and there were no differences between patients with or without 
PD. These results were maintained for the patients without PD at three and six months, whereas the comparable results for 
the PD-group were 38% and 54%. 
Conclusions: It is concluded that the 4-day treatment format is feasible also for patients with PD.
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obsessive-compulsive disorder (ocD) is 
characterized by intrusive, frequently occurring 
unwanted thoughts, or images (obsessions) that the 
patient unsuccessfully tries to get rid of by repetitively 
performing overt or mental rituals (compulsions), or 
engaging in avoidance behavior (american Psychiatric 
Association, 2013). Life time prevalence of OCD 
is estimated to be approximately 2 % (Ruscio et al. 
2008) and due to its tendency to become chronic 
without adequate treatment, OCD has been ranked 
among the 10 most debilitating disorders by the world 
Health Organization (Koran et al. 1996). Exposure-
based cognitive-behavioral treatments alone, or in 
combination with selective serotonin reuptake inhibitors 
(SSRIs) yield clinically significant results in 50-60% of 
the cases (Abramowitz 1998, Öst et al. 2015a, Rosa-
Alcázar and Sánchez-Meca 2008, Skapinakis et al. 
2016).
it has been suggested that treatment-outcome might 
be related to the magnitude and severity of comorbid 
disorders, and while some studies have reported a 
poorer treatment response in patients with comorbid 
axis-i disorders, where depression is the most common 
(Abramowitz 2004), a comprehensive meta-analysis 
by olatunji and colleagues (2010) indicates that pre-
treatment comorbidity is related to better treatment 
outcome (Olatunji et al. 2013). 
as for comorbid personality disorders (PD), the 
information is limited (Bulli et al. 2015) and the 
influence of a PD on treatment-outcome unclear (Thiel 
et al. 2013).While some have reported that the presence 
of personality disorders might predict a poorer outcome 
(Dreessen 1998), others have not found this association 
(Olatunji et al. 2010). One of the reasons for the scarce 
information about the prevalence of comorbid PD in 
treatment-seeking ocD-patients might be related to the 
time- and resource-demanding procedures needed for a 
full pre-treatment PD-screening interview(Thiel et al. 
2013). In the current paper we have employed a brief 
screening PD-interview, and the aims of the study were 
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to firstly relate the presence of a PD to OCD symptom 
severity pre-treatment as well as to explore possible 
relationships between comorbid PD and treatment 
outcome. Also, we want to explore whether co-morbid 
Axis-I disorders are related to treatment outcome.
exposure-based cBts can be delivered in a number 
of different formats (Öst et al. 2015b), and all patients 
in the current study received concentrated exposure 
Treatment (cET) delivered during four consecutive days. 
one of the hallmarks of this approach is the combination 
of individually tailored and therapist assisted exposures 
combined with a group format where the ratio between 
therapists and patients are 1:1 (havnen 2016; havnen 
et al. 2013; Havnen et al. 2014). The cET format has 
been evaluated in a pilot study (Havnen et al. 2013), 
in an effectiveness study (Havnen et al. 2014) and in 
a replication of the effectiveness study (Havnen et al. 
submitted) with very promising results. The format is 
highly accepted by the patients, and there are basically 
no drop-outs. Also, since the cET is delivered during 
a very short time-span, the approach yields a unique 
possibility to study treatment effects, since influence of 
external confounding factors is dramatically reduced. 
methods 
Referral procedures and description of the 
sample
the current study is part of a standard assessment- 
and quality control procedure in a specialized OCD 
outpatient clinic, haukeland university hospital, 
norway1. All adult OCD-patients in a catchment area 
of 400.000 are entitled to free health care at this clinic 
if the disorder is considered severe enough to require 
treatment. Patients with OCD, or suspected OCD, 
are referred from their general practitioners to the 
local district outpatient psychiatric facility, and then 
referred to the ocD clinic where they are screened 
with the norwegian version of mini-international 
Neuropsychiatric Interview (M.I.N.I.) (Leiknes et 
al. 2005) and Yale-Brown Obsessive-Compulsive 
scale (Y-BOCS) (Goodman et al. 1989). Patients 
who are diagnosed with ocD according to the Dsm-
iv-tr (american Psychiatric association 1994) are 
offered cET delivered in a group setting. The cET 
groups are arranged approximately 10 times per year, 
with a maximum of six participants, which means 
that patients are offered participation when slots 
are available. Patients with a primary diagnosis of 
psychosis, or suicidal thoughts are offered individual 
treatment. Personality disorder was assessed using 
the Standardized Assessment of Personality – 
Abbreviated Scale (SAPAS). Between November 2014 
and november 2015 48 of the 59 patients who were 
offered cET also had the SAPAS data available. Among 
these, one patient did not complete treatment, which 
left a sample of 47 (15 male), with a mean age of 32 
(range 20-63). 81% of the patients reported previous 
treatment, and 32% (15 patients) reported ongoing 
SSRI medication. 
Measures 
obsessive and compulsive symptoms was measured 
with the clinician-administered yale-Brown obsessive-
Compulsive Scale (Y-BOCS, (Goodman et al. 1989)) 
1  the study is approved by the local Data Protection 
Official, 2012/3663
the y-Bocs severity scale consists of 10 items, 5 
cover the severity of obsessions and 5 cover the severity 
of compulsions. Each item is rated from 0-4, and the 
total score ranges between 0-40. A score between 
0-7 is considered subclinical, between 8-15 mild, 16-
23 moderate, 24-31 severe, and 32-40 is considered 
indicative of extreme OCD (Marques et al. 2009). 
the y-Bocs has good psychometric properties 
with reported Cronbach’s α ranging from 0.88 to 
0.91(Goodman et al. 1989). 
The Standardized Assessment of Personality - 
abbreviated scale (saPas) is an eight-item screening 
interview for personality disorder (Moran et al. 2003) 
(see table 2 for overview of items). Each item is a 
question to be answered with “yes” or “no”. When the 
answer is “yes”, the interviewer asks whether this is 
generally the case (Moran et al. 2003). Previous studies 
have found a score of 4 or above to be indicative if a 
personality disorder (Germans et al. 2008, Gonzalez 
2014). The SAPAS is comprised of indicators covering 
multiple areas, and it is not designed to differentiate 
between the different PDs (Hesse and Moran 2010). 
The cET format2
Prior to the 4-day treatment, the patient receives 
psychoeducation about exposure and response-
prevention, and about the specific treatment format. 
it is ensured that they have made an active decision 
to participate. Each treatment group consists of 3-6 
patients, and the same number of therapists. Day one 
of the treatment (approximately 3h) the patients meet 
together for psychoeducation and detailed planning of 
exposure tasks for each patient (havnen 2016, havnen 
et al. 2013). The patients are encouraged to choose 
tasks that will enable the most useful changes, and that 
include the most challenging OCD symptoms. The 
aim is to fully approach all triggers without ”holding 
back” but rather “lean into” the anxiety by actively and 
willingly trying to increase the levels of anxiety and 
uncertainty. Day two and three (each approximately 8h) 
are reserved for therapist-assisted exposure training. 
Before individual exposures are initiated, an example 
of how to do exposures without holding back is 
demonstrated, and each patient starts the treatment by 
practicing the “leaning in technique” (LET-technique3). 
when exposures are conducted, the focus is on whether 
they are “leaning into” the anxiety and discomfort 
elicited by the triggers. Therapist assisted exposures are 
conducted in the most relevant contexts (at home, work, 
etc.). The group has short meetings in the morning, at 
lunch, and in the afternoon, where the patients share 
experiences. In the afternoon and evening the patients 
usually practice on their own, but texts/ call their 
therapist to give brief feedback focused on whether they 
are “leaning in” or not. During the afternoon day three 
a 2h psychoeducative meeting is held for the patient´s 
family and friends, with general information about the 
treatment, with special focus on issues related to family 
accommodation. Day four consists of a summary of the 
treatment experiences gained and the patients make a 
detailed plan for the following three weeks, to ensure 
that they implement the treatment principles in their 
daily life and continue to practice the principles of ERP. 
2  the norwegian manual for the cet format is under 
translation to English.
3  A standardized procedure for conducting the LET 
intervention is part of the cet manual 
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expectation maximization algorithm (Dempster et.al 
1977). Results are reported by using the Greenhouse-
Geisser correction. 
all statistical analyses were conducted using iBm 
SPSS Statistics, version 23.0. 
results
Pre-treatment symptom severity
y-Bocs mean pre-treatment score for the full 
sample was 24.15 (SD =3.8). 49% (23) patients had a 
y-Bocs score between 17 and 23, indicating moderate 
ocD; 45% (21) patients had scores between 24 and 30, 
indicating severe ocD; 6% (3) patients had a score of 
32 or above, indicating extreme OCD. 
77% of the patients had comorbid disorders. Among 
these, 11 had one, 13 had two, 8 had three, and 4 had 
four comorbid disorders. Please refer to table 1 for 
overview of distribution
the sample was divided into two groups (PD and 
nPD) based on SAPAS scores. 28% (n=13) of the 
patients had a SAPAS score equal or above the cut-off 
of 4, and was classified as PD. For distribution on each 
item, please refer to table 2.
Post-treatment: the patients continue to work with 
exposures in their daily life, and complete self-report 
questionnaires to monitor their progress. One week 
after treatment an independent rater conducts a y-Bocs 
interview, by phone, to assess change in OCD-symptoms. 
Follow-up: the patients are invited for an individual 
follow-up session three months after the treatment. This 
session does not contain any exposures but is focused on 
how to maintain and develop the change. Three and six 
months after treatment, the independent rater conducts 
a y-Bocs interview by phone, as part of the regular 
assessment of clinical effectiveness. 
Therapist competency4
the treatment was delivered at the ocD-team at 
Haukeland University Hospital. All therapists were 
highly experienced psychologists or psychiatrists with 
extensive experience with OCD-patients. All therapists 
had received hands-on training by the developers of 
the cET (Bjarne Hansen and Gerd Kvale). All had been 
certified as experts in the cET format, indicating that they 
are also considered competent to be a group leader. All 
therapists have in addition completed a comprehensive 
national OCD-training program focused on ERP. 
Clinically significant change
to determine the proportion of patients that obtained 
clinically significant improvement on OCD-symptoms, 
the criteria of Jacobson and Truax (1991) were applied. 
Here, we computed significant clinical change in 
Y-BOCS scores and categorized patients into 4 groups; 
no change, improved, remission and recovered. First, 
the change from pre- to post-assessment had to be 
large enough to be statistically reliable at the 5%-level 
(Reliable Change Index; RCI). Second, a cut-off score 
was used: the patient’s post-treatment score had to be 
within the distribution of the normal population defined 
as m+2sD, or outside the distribution of the patient 
population defined as M-2SD. In the present study the 
RCI used was ≥10 points reduction (Fisher and Wells, 
2005) and the cut-off score ≤14, in accordance with a 
previous study by the same research group (havnen et 
al., 2014). No change was defined as not fulfilling the 
RCI and scoring above the cut-off on the Y-BOCS (i.e. a 
reduction of less than 10 y-Bocs points, and a total score 
on the y-Bocs >14), improved was defined as fulfilling 
the RCI but not the cut-off score (i.e. a reduction of ≥10 
y-Bocs points from pre-treatment and a total y-Bocs 
score >14 points). Remission was defined as fulfilling the 
cut-off score (≤14), but less than 10 points reduction in 
y-Bocs score, and recovered was defined as fulfilling 
both the RCI and being below the cut off score (i.e. a 
reduction of ≥10 Y-BOCS points and a cut-off of ≤14). 
Statistical analysis
a mixed design anova with repeated measures 
(pre, post, 3-months and 6-months follow-up) was 
conducted to investigate the treatment effect, and 
potential differences between the PD and the nPD 
groups. Analogous analyses with the magnitude of 
comorbid Axis-I diagnoses as covariate were conducted. 
missing data at post treatment (8,5%) 3-months (14,9%) 
and 6-months (21,3%) were imputed by the aims of an 
4  Specifications for the training of therapists have 
been developed and are under translation to English.
Table 1. Distribution of comorbid Axis-I diagnoses as 
measured by M.I.N.I.
Diagnoses total PD group non-PD 
group





























Panic disorder 23.4% 11 30.1% 4 20.6% 7
GaD 21.3% 10 23.1% 3 20.6% 7
social phobia 21.3% 10 15.4% 2 23.5% 8
PtsD 6.4% 3 7.7% 1 5.9% 2
substance abuse 
disorder
4.3% 2 7.7% 1 2,9% 1
aDhD 2.1% 1 - 0 2.9% 1
hypomania 4.3% 2 7.7% 1 2,9% 1
anorexia nervosa 2.1% 1 - 0 2.9% 1
Table 2. Frequency Distribution of SAPAS Scores (N=47)
saPas items score 0
score 
1
1: In general, do you have difficulty making 
  and keeping friends?
35 12
2: would you normally describe yourself as 
    a loner?
39 8
3: in general, do you trust other people? 38 9
4: Do you normally lose your temper easily? 42 5
5: are you normally an impulsive sort of   
    person?
 16
6: are you normally a worrier? 8 39
7: in general, do you depend on others a lot? 29 18
8: in general, are you a perfectionist? 21 26
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recovered at post treatment, 38% (n=5) was classified 
as recovered at 3-months follow-up, and 54% (n=7) 
at 6-months follow-up, using the criteria for clinically 
significant change(Jacobson and Truax 1991). Please 
refer to table 4 for distribution. 
Discussion
the aim of the present study was to explore the 
relationship between comorbid personality disorder 
and treatment outcome in a treatment-seeking sample 
of ocD-patients that underwent a 4-day concentrated 
exposure treatment (cET). Also, we wanted to explore 
if comorbid axis-i disorders were related to treatment 
outcome. Since all patients with OCD, or suspected 
ocD, in the given catchment area are referred to this 
ocD clinic, the current unselected sample represent an 
opportunity to conduct research with high ecological 
validity and clinical relevance. Furthermore, since the 
intervention is delivered during 4 consecutive days, the 
design is highly relevant to study changes in symptoms 
from pre- to post treatment. 
the results showed clearly that the cet was highly 
effective. 79% of the total sample was classified as 
recovered post treatment, 68% as recovered at 3-months 
follow-up, and 72% as recovered at six months. This 
is comparable to our previous studies(Havnen et al. 
2013, 2014). These results are better than typical ERP-
Clinical changes in OCD-symptoms
an anova with repeated measures (pre, post, 3 m, 
6 m) for the whole sample, showed that the treatment 
was highly effective F(2.04,93.71) = 108.17, p = .000, 
also when the magnitude of axis i diagnoses was 
entered as co-variate. 
a mixed design analysis of variance showed the same 
large main effect of treatment F(2.15, 96.88) = 79.72, 
p = .000, and a significant interaction effect between 
treatment and PD F(2.15, 96.88) = 4.72, p = .009 was 
found (see figure 1). The significant interaction effect 
between time x PD was due to significant differences 
in Y-BOCS scores between patients with/ without 
PD at both 3 and 6-months follow-up. At 3-months, 
independent samples t-test showed the difference 
between the PD group (M = 14.92, SD = 8.20), and 
nPD group (M = 9.62, SD = 5.31); t(16.00) = -2.17, p 
= .046 (two tailed), indicating that the patients with PD 
had poorer treatment outcome at 3-months follow-up 
as compared to the patients without PD. The difference 
between the groups was still present at 6-months follow-
up, showing a slightly less favorable treatment outcome 
for the PD group: PD (M = 14.29, SD = 7.84), nPD (M = 
10.03, SD = 5.85); t(45) = -2.03, p = .049) (see table 3).
Despite significantly lower treatment outcome for 
patients with PD at 3-months as well as 6-months, 
69% (n=9) of the patients with PD was classified as 
Table 3. Comparison on Y-BOCS scores between PD group and non-PD group 
PD nPD
m sD n m sD n t-value
y-Bocs Pre 23.15 3.08 13 24.53 4.07 34 ns
y-Bocs Post 11.00 3.63 13 9.65 3.99 34 ns
y-Bocs 
3-months
14.92 8.20 13 9.62 5.31 34 -2.17*
y-Bocs 
6-months
14.29 7.84 13 10.03 5.85 34 -2.03*
*p <.05.
Figure 1. Y-BOCS scores for the PD and non-PD group at pre- and post-treatment, 
and at 3- and 6-month follow-up
*p<.05
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will yield comparable results. Recently, the concept 
of personality disorders has been debated (american 
Psychiatric association 2013) and in light of this, it 
would also be interesting to see if saPas scores are 
changed after treatment. 
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